Alerts will be sent to your verified email
Verify Email
MURAE
|
Murae Organisor
|
Biofil Chem & Pharma
|
Vivimed Labs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
5.64 % | 4.39 % | 10.89 % |
|
5yr average Equity Multiplier
|
2.09 | 2.06 | -33.72 |
|
5yr Average Asset Turnover Ratio
|
0.81 | 0.95 | 0.27 |
|
5yr Avg Net Profit Margin
|
5.31 % | 2.38 % | -54.08 % |
|
Price to Book
|
0.25 | 2.63 | 0.23 |
|
P/E
|
3.5 | 19.58 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
16.76 Days | 75.63 Days | 184.52 Days |
|
Inventory Days
|
424.86 Days | 28.27 Days | 244.76 Days |
|
Days Receivable
|
56.13 Days | 389.8 Days | 246.32 Days |
|
Days Payable
|
12.67 Days | 203.89 Days | 159.64 Days |
|
5yr Average Interest Coverage Ratio
|
538.35 | 23.53 | -6.61 |
|
5yr Avg ROCE
|
8.92 % | 6.37 % | -13.87 % |
|
5yr Avg Operating Profit Margin
|
-8.27 % | 3.78 % | -26.56 % |
|
5 yr average Debt to Equity
|
0.56 | 0.03 | -13.68 |
|
5yr CAGR Net Profit
|
142.32 % | -14.7 % | -14.97 % |
|
5yr Average Return on Assets
|
3.23 % | 2.37 % | -10.44 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 46.79 % | 7.77 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 14.8 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.03 % | -13.19 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Murae Organisor
|
Biofil Chem & Pharma
|
Vivimed Labs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|